Several clinical trials have found mesenchymal stem cell (MSC) therapy effective in treating neural damage in patients with multiple sclerosis (MS), according to a review published in Stem Cell Investigation.
Several clinical trials have found mesenchymal stem cell (MSC) therapy effective in treating neural damage in patients with multiple sclerosis (MS), according to a review published in Stem Cell Investigation.
SMSbiotech, Inc. is a California-based biotech company. Our goal is to revolutionize how the life sciences industry explores, examines, assesses and manipulates cells, drugs and toxins. Our stem cell technology will lead to the development of more efficient and relevant medicines.
1825 DIAMOND ST STE 101
SAN MARCOS, CA 92078
UNITED STATES
CALL US: 760-290-3406
EMAIL US: INFO@SMSBIOTECH.COM TECHNICALSUPPORT@SMSBIOTECH.COM
© 2019 - SMSbiotech. All Right Reserved.